← Open Payments lookup

ZHILA YADOLLAHI: Open Payments

NPI 1356916878 · MISSION HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,341 in 61 payments from 17 companies in 2025. Trend: 2023 $433 · 2024 $631 · 2025 $1,341

Food & beverage: $1,341
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$227
Novartis Pharmaceuticals Corporation11$207
Boehringer Ingelheim Pharmaceuticals, Inc.11$169
Amgen Inc.7$154
Aurinia Pharma U.S., Inc.5$101
Travere Therapeutics, Inc.3$69
Bayer Healthcare Pharmaceuticals Inc.3$55
Novo Nordisk Inc2$52
Calliditas Therapeutics US Inc.2$51
Otsuka America Pharmaceutical, Inc.3$50

Products named: JARDIANCE, FARXIGA, LOKELMA, LUPKYNIS, KRYSTEXXA, TAVNEOS, Kerendia, Ozempic.

Industry payments across CA — which companies pay providers there.